This report shows how biopharmaceutical research companies continue to be vitally important to the economy and patient health in Oregon.

Since 2004, biopharmaceutical research companies have conducted or are conducting more than 5,000 clinical trials of new medicines in Oregon in collaboration with clinical research centers, hospitals, and local research institutions. These clinical trials have investigated or are investigating some of Oregon’s biggest health care challenges, including asthma, arthritis, cancer, infectious diseases, cardiovascular disease and gastrointestinal diseases.

“Biomedical startups dream of reaching the clinical trial phase with their ideas. Support from our state, whether that be investments or policies, make it so more innovators can thrive in Oregon and see their dreams come true. Making a difference in the lives of patients and their families is a great return on investment.” – Heather Ellis Executive Director, Oregon Translational Research and Development Institute (OTRADI) and Oregon Bioscience Incubator (OBI)